ReviewJournal of community genetics2026
Strengthening legal safeguards against genetic discrimination: review and recommendations for Malaysia.
Review in Journal of community genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The increased pace of genomic research and precision medicine on a global scale has heightened the risk of genetic discrimination and underscored the critical importance of genetic data protection. Leading jurisdictions, including the U.S., the European Union, Japan, China and Hong Kong among others, have enacted laws as solution to these issues. These regulations explicitly outlaw the misuse of genetic information in insurance, employment, or health-related domains in addition to robust data protection measures, which include defined opt-in requirements and proper governance by auditors and ethics committees. Malaysia, however, is yet to have legal safeguards specifically against genetic discrimination, currently relying on general data protection laws that does not explicitly classify genetic information as sensitive or protected data, thus making it vulnerable to discriminatory misuse. This gap has implications towards the general population, especially with the rise of genetic testing in healthcare and large-scale genomics studies. This review examines existing international legal guidelines and policy infrastructure relevant to genetic discrimination and genetic data governance, through which key mechanisms of anti-discrimination legislation, data privacy schemes, and bioethics criteria are identified. The consistently repeated tenets such as explicit prohibitions on discriminatory uses of genetic data, expanded safeguards and strong supervisory mechanisms, when applied to the Malaysian context, serve as a legislative blueprint for the country to establish its own framework in preventing genetic discrimination, addressing current protection gaps, and governing genetic data in the spheres of research, insurance, employment, and commercialisation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.